IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 33 filers reported holding IMPEL NEUROPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LASRY MARC | 408,329 | $1,989,000 | 3.82% |
| venBio Partners LLC | 2,759,791 | $13,440,000 | 3.11% |
| 5AM Venture Management, LLC | 2,884,791 | $14,049,000 | 2.69% |
| Vivo Capital, LLC | 2,884,789 | $14,049,000 | 1.55% |
| DCF Advisers, LLC | 469,183 | $2,285,000 | 1.48% |
| Opaleye Management Inc. | 255,250 | $1,243,000 | 0.51% |
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $20,142,000 | 0.40% |
| EPIQ PARTNERS, LLC | 18,646 | $91,000 | 0.06% |
| GILDER GAGNON HOWE & CO LLC | 142,696 | $695,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 68,300 | $333,000 | 0.01% |